Routine remote symptom monitoring using electronic patient-reported outcomes (ePROs) allows cancer patients to stay on systemic therapies longer, lowers adverse event rates, and reduces overall healthcare costs, according to recent findings presented by Dr. Debra Patt at the American Society of Clinical Oncology (ASCO) Annual Meeting.
Evolution of Remote Symptom Monitoring in Cancer Care
The latest real-world evidence builds on nearly a decade of research validating digital symptom tracking. Landmark data presented in 2017 first established that routine collection of electronic patient-reported outcomes enables patients to maintain their treatment schedules longer while delivering an overall survival benefit. Subsequent studies across diverse practice settings have continued to reinforce those findings, shifting how clinicians view supportive care.
According to Dr. Debra Patt, executive vice president of Texas Oncology and president of the Community Oncology Alliance, this expanding data pool represents a fundamental shift in oncology management. Continuous electronic symptom tracking is no longer just an incremental addition to supportive care. Instead, it is rapidly becoming a core standard for managing patients receiving therapies with complex toxicity profiles.
Did you know?
Landmark research from 2017 initially proved that routine electronic tracking of symptoms could actively extend the time patients remain on vital cancer treatments.
Real-World Impact and Cost Reductions in Community Settings
Recent multicenter analyses highlight the tangible benefits of integrating digital engagement tools into everyday clinical workflows. Research conducted within Texas Oncology and detailed in a multicenter real-world analysis presented at the ASCO Annual Meeting demonstrates clear advantages. Practices utilizing remote symptom monitoring see improved time on therapy, fewer treatment-related adverse events, and notable reductions in overall healthcare utilization.
For community oncology practices, these digital tools serve a vital triage function. By capturing toxicities earlier, care teams can intervene proactively before minor complications escalate into emergencies requiring hospitalization. A recent real-world analysis by Essell et al., published in the Journal of Clinical Oncology (2026), specifically highlights the impact of remote therapeutic monitoring with patient-reported outcomes on reducing hospitalizations for patients receiving therapy for metastatic solid tumors.
Standardizing ePROs for High-Toxicity Systemic Therapies
Dr. Patt emphasizes that incorporating these technologies supports more efficient delivery of oncology care in community settings. By streamlining toxicity management, clinics optimize staff resources while shielding patients from avoidable emergency room visits and inpatient admissions.
Pro Tip for Practices:
Frequently Asked Questions
What are electronic patient-reported outcomes (ePROs)?
ePROs are digital tools that allow patients to report their symptoms, side effects, and overall well-being directly to their healthcare team from home.
How do ePROs improve cancer treatment outcomes?
According to research discussed at the ASCO Annual Meeting, routine ePRO monitoring allows clinicians to intervene earlier regarding toxicities, helping patients stay on their prescribed therapies longer and reducing hospitalizations.
Do ePROs reduce healthcare costs?
Yes. Multicenter real-world analyses show that remote symptom tracking cuts overall healthcare costs primarily by preventing avoidable emergency department visits and hospital admissions.
Stay Informed on Oncology Innovations
Explore our latest coverage on clinical trials, digital health trends, and community oncology updates. Subscribe to our newsletter for direct updates.
Keep reading